Abstract
Over the years, allogeneic lung transplantation (LTx) has become a promising therapy for end-stage lung diseases patients. Unfortunately, LTx is limited by both the low number and poor quality of donated organs, and by the fact that lungs are very vulnerable to ischemia reperfusion injury (IRI), which can lead to graft dysfunction. Over the last decades, the survival and clinical outcomes of lung transplant patients have significantly improved worldwide, despite morbidity and mortality for LTx remaining high compared to other solid organ transplants.
Many advances in both basic and clinical research on LTx have emerged over the years. For instance, xenografts or bioartificial lung grafts have been studied in several animal models as an alternative approach to allogeneic LTx, but this research is still ongoing to determine its prolonged efficacy in humans. Many challenges including expanding the donor pool, inducing graft tolerance, and preventing post-transplant complications must yet be overcome to align LTx outcomes with those of other organ transplants.
Recently, ex vivo lung perfusion (EVLP) techniques have been used as a promising strategy to improve the number and the quality of lung donor grafts, with consequent reduction of post-transplant complications. The success of LTx is strongly correlated with the quality and consequent function of the lung graft and, hence, EVLP is seen as an opportunity to protect and/or repair the lungs prior to transplantation. Many researchers support the use of mesenchymal stromal/stem cells (MSCs) as a therapeutic approach to advance EVLP and, considering that these cells are believed to be capable of inducing tolerance during solid organ transplantation, MSCs can be considered a useful strategy to increase EVLP performance. Therefore, during EVLP, the administration of MSC and/or their products might pave the way for a new approach capable of increasing EVLP efficacy with the aim of improving LTx outcomes. The purpose of this chapter is to review the recent research advances in the field of LTx.
Abbreviations
- AdMSCs:
-
Adipose-derived MSCs
- ALI:
-
Acute lung injury
- AMSCs:
-
Amnion-derived MSCs
- ARDS:
-
Acute respiratory distress syndrome
- BAL:
-
Bronchoalveolar lavage
- BM-MSCs:
-
Bone marrow-derived MSCs
- CLAD:
-
Chronic lung allograft dysfunction
- CM:
-
Conditioned medium
- DCD:
-
Donation after circulatory death
- EVLP:
-
Ex vivo lung perfusion
- EVs:
-
Extracellular vesicles
- EXOs:
-
Exosomes
- IRI:
-
Ischemia reperfusion injury
- LTx:
-
Lung transplantation
- MSCs:
-
Mesenchymal stromal/stem cells
- PGD:
-
Primary graft dysfunction
- ROS:
-
Reactive oxygen species
- UC-MSCs:
-
Umbilical cord-derived MSCs
References
Abreu SC, Weiss DJ, Rocco PR (2016) Extracellular vesicles derived from mesenchymal stromal cells: a therapeutic option in respiratory diseases? Stem Cell Res Ther 7(1):53
Abreu SC, Antunes MA, Xisto DG, Cruz FF, Branco VC, Bandeira E, Zola Kitoko J, de Araujo AF, Dellatorre-Texeira L, Olsen PC, Weiss DJ, Diaz BL, Morales MM, Rocco PRM (2017) Bone marrow, adipose, and lung tissue-derived murine mesenchymal stromal cells release different mediators and differentially affect airway and lung parenchyma in experimental asthma. Stem Cells Transl Med 6(6):1557–1567
Asimacopoulos PJ, Molokhia FA, Pegg CA, Norman JC (1971) Lung transplantation in the rat. Transplant Proc 3(1):583–585
Asmussen S, Ito H, Traber DL, Lee JW, Cox RA, Hawkins HK, McAuley DF, McKenna DH, Traber LD, Zhuo H, Wilson J, Herndon DN, Prough DS, Liu KD, Matthay MA, Enkhbaatar P (2014) Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia. Thorax 69(9):819–825
Bozso S, Vasanthan V, Luc JG, Kinaschuk K, Freed D, Nagendran J (2015) Lung transplantation from donors after circulatory death using portable ex vivo lung perfusion. Can Respir J 22(1):47–51
Bredenoord AL, Clevers H, Knoblich JA (2017) Human tissues in a dish: the research and ethical implications of organoid technology. Science 355(6322):eaaf9414
Bronisz A, Godlewski J, Chiocca EA (2016) Extracellular vesicles and MicroRNAs: their role in tumorigenicity and therapy for brain tumors. Cell Mol Neurobiol 36(3):361–376
Bulati M, Miceli V, Gallo A, Amico G, Carcione C, Pampalone M, Conaldi PG (2020) The immunomodulatory properties of the human amnion-derived mesenchymal stromal/stem cells are induced by INF-gamma produced by activated lymphomonocytes and are mediated by cell-to-cell contact and soluble factors. Front Immunol 11:54
Burdorf L, Azimzadeh AM, Pierson RN 3rd (2020) Xenogeneic lung transplantation models. Methods Mol Biol 2110:173–196
Caplan AI (1991) Mesenchymal stem cells. J Orthop Res 9(5):641–650
Chambers DC, Enever D, Lawrence S, Sturm MJ, Herrmann R, Yerkovich S, Musk M, Hopkins PM (2017) Mesenchymal stromal cell therapy for chronic lung allograft dysfunction: results of a first-in-man study. Stem Cells Transl Med 6(4):1152–1157
Charles EJ, Huerter ME, Wagner CE, Sharma AK, Zhao Y, Stoler MH, Mehaffey JH, Isbell JM, Lau CL, Tribble CG, Laubach VE, Kron IL (2016) Donation after circulatory death lungs transplantable up to six hours after ex vivo lung perfusion. Ann Thorac Surg 102(6):1845–1853
Chen S, Cui G, Peng C, Lavin MF, Sun X, Zhang E, Yang Y, Guan Y, Du Z, Shao H (2018) Transplantation of adipose-derived mesenchymal stem cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats. Stem Cell Res Ther 9(1):110
Christie JD, Kotloff RM, Ahya VN, Tino G, Pochettino A, Gaughan C, DeMissie E, Kimmel SE (2005) The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 171(11):1312–1316
Cooper DK, Ekser B, Burlak C, Ezzelarab M, Hara H, Paris L, Tector AJ, Phelps C, Azimzadeh AM, Ayares D, Robson SC, Pierson RN 3rd (2012) Clinical lung xenotransplantation--what donor genetic modifications may be necessary? Xenotransplantation 19(3):144–158
Cypel M, Yeung JC, Machuca T, Chen M, Singer LG, Yasufuku K, de Perrot M, Pierre A, Waddell TK, Keshavjee S (2012) Experience with the first 50 ex vivo lung perfusions in clinical transplantation. J Thorac Cardiovasc Surg 144(5):1200–1206
Dabrowska S, Andrzejewska A, Janowski M, Lukomska B (2020) Immunomodulatory and regenerative effects of mesenchymal stem cells and extracellular vesicles: therapeutic outlook for inflammatory and degenerative diseases. Front Immunol 11:591065
de Perrot M, Keshavjee S (2003) Lung transplantation. Lung preservation. Chest Surg Clin N Am 13(3):443–462
de Perrot M, Liu M, Waddell TK, Keshavjee S (2003) Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 167(4):490–511
Degirmenci B, Valenta T, Dimitrieva S, Hausmann G, Basler K (2018) GLI1-expressing mesenchymal cells form the essential Wnt-secreting niche for colon stem cells. Nature 558(7710):449–453
den Hengst WA, Gielis JF, Lin JY, Van Schil PE, De Windt LJ, Moens AL (2010) Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol 299(5):H1283–H1299
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315–317
Eefting F, Rensing B, Wigman J, Pannekoek WJ, Liu WM, Cramer MJ, Lips DJ, Doevendans PA (2004) Role of apoptosis in reperfusion injury. Cardiovasc Res 61(3):414–426
Ekser B, Bianchi J, Ball S, Iwase H, Walters A, Ezzelarab M, Veroux M, Gridelli B, Wagner R, Ayares D, Cooper DK (2012) Comparison of hematologic, biochemical, and coagulation parameters in alpha1,3-galactosyltransferase gene-knockout pigs, wild-type pigs, and four primate species. Xenotransplantation 19(6):342–354
Esrefoglu M (2013) Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure. World J Gastroenterol 19(40):6757–6773
Farre R, Otero J, Almendros I, Navajas D (2018) Bioengineered lungs: a challenge and an opportunity. Arch Bronconeumol (Engl Ed) 54(1):31–38
Fisher AB, Dodia C, Tan ZT, Ayene I, Eckenhoff RG (1991) Oxygen-dependent lipid peroxidation during lung ischemia. J Clin Invest 88(2):674–679
Foronjy RF, Majka SM (2012) The potential for resident lung mesenchymal stem cells to promote functional tissue regeneration: understanding microenvironmental cues. Cell 1(4):874
Fouraschen SM, Pan Q, de Ruiter PE, Farid WR, Kazemier G, Kwekkeboom J, Ijzermans JN, Metselaar HJ, Tilanus HW, de Jonge J, van der Laan LJ (2012) Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomy. Stem Cells Dev 21(13):2410–2419
Frick AE, Orlitova M, Vanstapel A, Ordies S, Claes S, Schols D, Heigl T, Kaes J, Saez-Gimenez B, Vos R, Verleden GM, Vanaudenaerde B, Verleden SE, Van Raemdonck DE, Neyrinck AP (2021) A novel experimental porcine model to assess the impact of differential pulmonary blood flow on ischemia-reperfusion injury after unilateral lung transplantation. Intensive Care Med Exp 9(1):4
Fu Y, Karbaat L, Wu L, Leijten J, Both SK, Karperien M (2017) Trophic effects of mesenchymal stem cells in tissue regeneration. Tissue Eng Part B Rev 23(6):515–528
Gallo A, Cuscino N, Contino F, Bulati M, Pampalone M, Amico G, Zito G, Carcione C, Centi C, Bertani A, Conaldi PG, Miceli V (2022) Changes in the transcriptome profiles of human amnion-derived mesenchymal stromal/stem cells induced by three-dimensional culture: a potential priming strategy to improve their properties. Int J Mol Sci 23:2
Gennai S, Monsel A, Hao Q, Park J, Matthay MA, Lee JW (2015) Microvesicles derived from human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 15(9):2404–2412
Grange C, Bellucci L, Bussolati B, Ranghino A (2020) Potential applications of extracellular vesicles in solid organ transplantation. Cell 9:2
Guillamat-Prats R, Camprubi-Rimblas M, Puig F, Herrero R, Tantinya N, Serrano-Mollar A, Artigas A (2020) Alveolar type II cells or mesenchymal stem cells: comparison of two different cell therapies for the treatment of acute lung injury in rats. Cell 9(8):1816
Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA (2007) Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179(3):1855–1863
Huerter ME, Sharma AK, Zhao Y, Charles EJ, Kron IL, Laubach VE (2016) Attenuation of pulmonary ischemia-reperfusion injury by adenosine A2B receptor antagonism. Ann Thorac Surg 102(2):385–393
Hwang B, Liles WC, Waworuntu R, Mulligan MS (2016) Pretreatment with bone marrow-derived mesenchymal stromal cell-conditioned media confers pulmonary ischemic tolerance. J Thorac Cardiovasc Surg 151(3):841–849
Ide N, Nagayasu T, Matsumoto K, Tagawa T, Tanaka K, Taguchi T, Sumida Y, Nakashima M (2007) Efficacy and safety of inhaled tacrolimus in rat lung transplantation. J Thorac Cardiovasc Surg 133(2):548–553
Ionescu L, Byrne RN, van Haaften T, Vadivel A, Alphonse RS, Rey-Parra GJ, Weissmann G, Hall A, Eaton F, Thebaud B (2012) Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. Am J Physiol Lung Cell Mol Physiol 303(11):L967–L977
Jarvinen L, Badri L, Wettlaufer S, Ohtsuka T, Standiford TJ, Toews GB, Pinsky DJ, Peters-Golden M, Lama VN (2008) Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. J Immunol 181(6):4389–4396
Jin X, Kaes J, Van Slambrouck J, Inci I, Arni S, Geudens V, Heigl T, Jansen Y, Carlon MS, Vos R, Van Raemdonck D, Zhang Y, Vanaudenaerde BM, Ceulemans LJ (2022) A comprehensive review on the surgical aspect of lung transplant models in mice and rats. Cells 11(3):480
Khush KK, Cherikh WS, Chambers DC, Goldfarb S, Hayes D Jr, Kucheryavaya AY, Levvey BJ, Meiser B, Rossano JW, Stehlik J, International Society for Heart and Lung Transplantation (2018) The international thoracic organ transplant registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult heart transplantation Report-2018; focus theme: multiorgan transplantation. J Heart Lung Transplant 37(10):1155–1168
Kittai AS, Oldham H, Cetnar J, Taylor M (2017) Immune checkpoint inhibitors in organ transplant patients. J Immunother 40(7):277–281
Konala VB, Mamidi MK, Bhonde R, Das AK, Pochampally R, Pal R (2016) The current landscape of the mesenchymal stromal cell secretome: a new paradigm for cell-free regeneration. Cytotherapy 18(1):13–24
Kossl J, Bohacova P, Hermankova B, Javorkova E, Zajicova A, Holan V (2021) Antiapoptotic properties of mesenchymal stem cells in a mouse model of corneal inflammation. Stem Cells Dev 30(8):418–427
Krishnadasan B, Naidu BV, Byrne K, Fraga C, Verrier ED, Mulligan MS (2003) The role of proinflammatory cytokines in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 125(2):261–272
Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11(9):597–610
Kronstadt SM, Pottash AE, Levy D, Wang S, Chao W, Jay SM (2021) Therapeutic potential of extracellular vesicles for sepsis treatment. Adv Ther (Weinh) 4(7):2000259
Kubicki N, Laird C, Burdorf L, Pierson RN 3rd, Azimzadeh AM (2015) Current status of pig lung xenotransplantation. Int J Surg 23(Pt B):247–254
La Francesca S, Ting AE, Sakamoto J, Rhudy J, Bonenfant NR, Borg ZD, Cruz FF, Goodwin M, Lehman NA, Taggart JM, Deans R, Weiss DJ (2014) Multipotent adult progenitor cells decrease cold ischemic injury in ex vivo perfused human lungs: an initial pilot and feasibility study. Transplant Res 3(1):19
Lama VN, Belperio JA, Christie JD, El-Chemaly S, Fishbein MC, Gelman AE, Hancock WW, Keshavjee S, Kreisel D, Laubach VE, Looney MR, McDyer JF, Mohanakumar T, Shilling RA, Panoskaltsis-Mortari A, Wilkes DS, Eu JP, Nicolls MR (2017) Models of lung transplant research: a consensus statement from the National Heart, Lung, and Blood Institute workshop. JCI Insight 2:9
Laubach VE, Sharma AK (2016) Mechanisms of lung ischemia-reperfusion injury. Curr Opin Organ Transplant 21(3):246–252
Lavoie JR, Rosu-Myles M (2013) Uncovering the secretes of mesenchymal stem cells. Biochimie 95(12):2212–2221
Lee JW, Fang X, Gupta N, Serikov V, Matthay MA (2009) Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A 106(38):16357–16362
Lee JW, Fang X, Krasnodembskaya A, Howard JP, Matthay MA (2011) Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Stem Cells 29(6):913–919
Lee JK, Park SR, Jung BK, Jeon YK, Lee YS, Kim MK, Kim YG, Jang JY, Kim CW (2013) Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One 8(12):e84256
Li JH, Zhang N, Wang JA (2008) Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy. J Endocrinol Investig 31(2):103–110
Li JW, Wei L, Han Z, Chen Z (2019) Mesenchymal stromal cells-derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p. Eur J Pharmacol 852:68–76
Lin KC, Yeh JN, Chen YL, Chiang JY, Sung PH, Lee FY, Guo J, Yip HK (2020) Xenogeneic and allogeneic mesenchymal stem cells effectively protect the lung against ischemia-reperfusion injury through downregulating the inflammatory, oxidative stress, and autophagic signaling pathways in rat. Cell Transplant 29:963689720954140
Lo Nigro A, Gallo A, Bulati M, Vitale G, Paini DS, Pampalone M, Galvagno D, Conaldi PG, Miceli V (2021) Amnion-derived mesenchymal stromal/stem cell paracrine signals potentiate human liver organoid differentiation: translational implications for liver regeneration. Front Med 8:746298
Lonati C, Bassani GA, Brambilla D, Leonardi P, Carlin A, Maggioni M, Zanella A, Dondossola D, Fonsato V, Grange C, Camussi G, Gatti S (2019) Mesenchymal stem cell-derived extracellular vesicles improve the molecular phenotype of isolated rat lungs during ischemia/reperfusion injury. J Heart Lung Transplant 38(12):1306–1316
Looze C, Yui D, Leung L, Ingham M, Kaler M, Yao X, Wu WW, Shen RF, Daniels MP, Levine SJ (2009) Proteomic profiling of human plasma exosomes identifies PPARgamma as an exosome-associated protein. Biochem Biophys Res Commun 378(3):433–438
Lu H, Poirier C, Cook T, Traktuev DO, Merfeld-Clauss S, Lease B, Petrache I, March KL, Bogatcheva NV (2015) Conditioned media from adipose stromal cells limit lipopolysaccharide-induced lung injury, endothelial hyperpermeability and apoptosis. J Transl Med 13:67
Mariscal A, Caldarone L, Tikkanen J, Nakajima D, Chen M, Yeung J, Cypel M, Liu M, Keshavjee S (2018) Pig lung transplant survival model. Nat Protoc 13(8):1814–1828
Martens A, Boada M, Vanaudenaerde BM, Verleden SE, Vos R, Verleden GM, Verbeken EK, Van Raemdonck D, Schols D, Claes S, Neyrinck AP (2016) Steroids can reduce warm ischemic reperfusion injury in a porcine donation after circulatory death model with ex vivo lung perfusion evaluation. Transpl Int 29(11):1237–1246
Martens A, Ordies S, Vanaudenaerde BM, Verleden SE, Vos R, Van Raemdonck DE, Verleden GM, Roobrouck VD, Claes S, Schols D, Verbeken E, Verfaillie CM, Neyrinck AP (2017) Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model. Stem Cell Res Ther 8(1):159
McAuley DF, Curley GF, Hamid UI, Laffey JG, Abbott J, McKenna DH, Fang X, Matthay MA, Lee JW (2014) Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation. Am J Physiol Lung Cell Mol Physiol 306(9):L809–L815
Meier RP, Muller YD, Morel P, Gonelle-Gispert C, Buhler LH (2013) Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence? Stem Cell Res 11(3):1348–1364
Miceli V, Bertani A (2022) Mesenchymal stromal/stem cells and their products as a therapeutic tool to advance lung transplantation. Cell 11:5
Miceli V, Pampalone M, Vella S, Carreca AP, Amico G, Conaldi PG (2019) Comparison of immunosuppressive and angiogenic properties of human amnion-derived mesenchymal stem cells between 2D and 3D culture systems. Stem Cells Int 2019:7486279
Miceli V, Chinnici CM, Bulati M, Pampalone M, Amico G, Schmelzer E, Gerlach JC, Conaldi PG (2020) Comparative study of the production of soluble factors in human placenta-derived mesenchymal stromal/stem cells grown in adherent conditions or as aggregates in a catheter-like device. Biochem Biophys Res Commun 522(1):171–176
Miceli V, Bulati M, Iannolo G, Zito G, Gallo A, Conaldi PG (2021a) Therapeutic properties of mesenchymal stromal/stem cells: the need of cell priming for cell-free therapies in regenerative medicine. Int J Mol Sci 22:2
Miceli V, Bertani A, Chinnici CM, Bulati M, Pampalone M, Amico G, Carcione C, Schmelzer E, Gerlach JC, Conaldi PG (2021b) Conditioned medium from human amnion-derived mesenchymal stromal/stem cells attenuating the effects of cold ischemia-reperfusion injury in an in vitro model using human alveolar epithelial cells. Int J Mol Sci 22(2):510
Mohammadipoor A, Antebi B, Batchinsky AI, Cancio LC (2018) Therapeutic potential of products derived from mesenchymal stem/stromal cells in pulmonary disease. Respir Res 19(1):218
Mordant P, Nakajima D, Kalaf R, Iskender I, Maahs L, Behrens P, Coutinho R, Iyer RK, Davies JE, Cypel M, Liu M, Waddell TK, Keshavjee S (2016) Mesenchymal stem cell treatment is associated with decreased perfusate concentration of interleukin-8 during ex vivo perfusion of donor lungs after 18-hour preservation. J Heart Lung Transplant 35(10):1245–1254
Moreira A, Naqvi R, Hall K, Emukah C, Martinez J, Moreira A, Dittmar E, Zoretic S, Evans M, Moses D, Mustafa S (2020) Effects of mesenchymal stromal cell-conditioned media on measures of lung structure and function: a systematic review and meta-analysis of preclinical studies. Stem Cell Res Ther 11(1):399
Morrison TJ, Jackson MV, Cunningham EK, Kissenpfennig A, McAuley DF, O’Kane CM, Krasnodembskaya AD (2017) Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer. Am J Respir Crit Care Med 196(10):1275–1286
Nakajima D, Watanabe Y, Ohsumi A, Pipkin M, Chen M, Mordant P, Kanou T, Saito T, Lam R, Coutinho R, Caldarone L, Juvet S, Martinu T, Iyer RK, Davies JE, Hwang DM, Waddell TK, Cypel M, Liu M, Keshavjee S (2019) Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation. J Heart Lung Transplant 38(11):1214–1223
Nelson K, Bobba C, Ghadiali S, Hayes D Jr, Black SM, Whitson BA (2014) Animal models of ex vivo lung perfusion as a platform for transplantation research. World J Exp Med 4(2):7–15
Okazaki M, Krupnick AS, Kornfeld CG, Lai JM, Ritter JH, Richardson SB, Huang HJ, Das NA, Patterson GA, Gelman AE, Kreisel D (2007) A mouse model of orthotopic vascularized aerated lung transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 7(6):1672–1679
Ott HC, Clippinger B, Conrad C, Schuetz C, Pomerantseva I, Ikonomou L, Kotton D, Vacanti JP (2010) Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 16(8):927–933
Pacienza N, Santa-Cruz D, Malvicini R, Robledo O, Lemus-Larralde G, Bertolotti A, Marcos M, Yannarelli G (2019) Mesenchymal stem cell therapy facilitates donor lung preservation by reducing oxidative damage during ischemia. Stem Cells Int 2019:8089215
Park J, Kim S, Lim H, Liu A, Hu S, Lee J, Zhuo H, Hao Q, Matthay MA, Lee JW (2019) Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe E. coli pneumonia. Thorax 74(1):43–50
Podesta MA, Remuzzi G, Casiraghi F (2019) Mesenchymal stromal cells for transplant tolerance. Front Immunol 10:1287
Poggi A, Zocchi MR (2019) Immunomodulatory properties of mesenchymal stromal cells: still unresolved “Yin and Yang”. Curr Stem Cell Res Ther 14(4):344–350
Porteous MK, Lee JC (2017) Primary graft dysfunction after lung transplantation. Clin Chest Med 38(4):641–654
Puga Yung GL, Li Y, Borsig L, Millard AL, Karpova MB, Zhou D, Seebach JD (2012) Complete absence of the alphaGal xenoantigen and isoglobotrihexosylceramide in alpha1,3galactosyltransferase knock-out pigs. Xenotransplantation 19(3):196–206
Reiter J, Drummond S, Sammour I, Huang J, Florea V, Dornas P, Hare JM, Rodrigues CO, Young KC (2017) Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia. Respir Res 18(1):137
Roffia V, De Palma A, Lonati C, Di Silvestre D, Rossi R, Mantero M, Gatti S, Dondossola D, Valenza F, Mauri P, Blasi F (2018) Proteome investigation of rat lungs subjected to ex vivo perfusion (EVLP). Molecules 23:12
Rosso L, Zanella A, Righi I, Barilani M, Lazzari L, Scotti E, Gori F, Mendogni P (2018) Lung transplantation, ex-vivo reconditioning and regeneration: state of the art and perspectives. J Thorac Dis 10(Suppl 20):S2423–S2430
Ryan JM, Barry FP, Murphy JM, Mahon BP (2005) Mesenchymal stem cells avoid allogeneic rejection. J Inflamm 2:8
Sahara H, Watanabe H, Pomposelli T, Yamada K (2017) Lung xenotransplantation. Curr Opin Organ Transplant 22(6):541–548
Shin J, Hsin MK, Baciu C, Chen Y, Zamel R, Machuca T, Yeung J, Cypel M, Keshavjee S, Liu M (2021) Use of metabolomics to identify strategies to improve and prolong ex vivo lung perfusion for lung transplants. J Heart Lung Transplant 40(6):525–535
Shologu N, Scully M, Laffey JG, O’Toole D (2018) Human mesenchymal stem cell secretome from bone marrow or adipose-derived tissue sources for treatment of hypoxia-induced pulmonary epithelial injury. Int J Mol Sci 19(10):2996
Stavely R, Nurgali K (2020) The emerging antioxidant paradigm of mesenchymal stem cell therapy. Stem Cells Transl Med 9(9):985–1006
Stone ML, Zhao Y, Robert Smith J, Weiss ML, Kron IL, Laubach VE, Sharma AK (2017) Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death. Respir Res 18, (1):212
Sun CK, Yen CH, Lin YC, Tsai TH, Chang LT, Kao YH, Chua S, Fu M, Ko SF, Leu S, Yip HK (2011) Autologous transplantation of adipose-derived mesenchymal stem cells markedly reduced acute ischemia-reperfusion lung injury in a rodent model. J Transl Med 9:118
Sun H, Deng M, Chen W, Liu M, Dai H, Wang C (2022) Graft dysfunction and rejection of lung transplant, a review on diagnosis and management. Clin Respir J 16(1):5–12
Szabolcs P, Buckley RH, Davis RD, Moffet J, Voynow J, Antony J, Chen X, Sempowski GD, Zaas DW (2015) Tolerance and immunity after sequential lung and bone marrow transplantation from an unrelated cadaveric donor. J Allergy Clin Immunol 135(2):567–570
Tao H, Han Z, Han ZC, Li Z (2016) Proangiogenic features of mesenchymal stem cells and their therapeutic applications. Stem Cells Int 2016:1314709
Thabut G, Mal H (2017) Outcomes after lung transplantation. J Thorac Dis 9(8):2684–2691
Tian W, Liu Y, Zhang B, Dai X, Li G, Li X, Zhang Z, Du C, Wang H (2015) Infusion of mesenchymal stem cells protects lung transplants from cold ischemia-reperfusion injury in mice. Lung 193(1):85–95
van der Mark SC, Hoek RAS, Hellemons ME (2020) Developments in lung transplantation over the past decade. Eur Respir Rev 29:157
Weyker PD, Webb CA, Kiamanesh D, Flynn BC (2013) Lung ischemia reperfusion injury: a bench-to-bedside review. Semin Cardiothorac Vasc Anesth 17(1):28–43
Wosczyna MN, Konishi CT, Perez Carbajal EE, Wang TT, Walsh RA, Gan Q, Wagner MW, Rando TA (2019) Mesenchymal stromal cells are required for regeneration and homeostatic maintenance of skeletal muscle. Cell Rep 27(7):2029–2035.e5
Xia C, Dai Z, Jin Y, Chen P (2021) Emerging antioxidant paradigm of mesenchymal stem cell-derived exosome therapy. Front Endocrinol 12:727272
Yang F, Ning Z, Ma L, Liu W, Shao C, Shu Y, Shen H (2017) Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts. Mol Cancer 16(1):148
Yano M, Omoto Y, Yamakawa Y, Nakashima Y, Kiriyama M, Saito Y, Fujii Y (2001) Increased matrix metalloproteinase 9 activity and mRNA expression in lung ischemia-reperfusion injury. J Heart Lung Transplant 20(6):679–686
Zhai W, Ge J, Inci I, Hillinger S, Markus C, Korom S, Weder W (2008) Simplified rat lung transplantation by using a modified cuff technique. J Invest Surg 21(1):33–37
Zhu YG, Feng XM, Abbott J, Fang XH, Hao Q, Monsel A, Qu JM, Matthay MA, Lee JW (2014) Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells 32(1):116–125
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 UPMC Italy S.R.L.
About this entry
Cite this entry
Miceli, V., Bertani, A., Pagano, V., Centi, C., Conaldi, P.G. (2023). Building Basic and Clinical Research Around Lung Transplantation. In: Bertani, A., Vitulo, P., Grossi, P.A. (eds) Contemporary Lung Transplantation. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-20788-9_48-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-20788-9_48-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20788-9
Online ISBN: 978-3-319-20788-9
eBook Packages: Springer Reference MedicineReference Module Medicine